ID: ALA4648848

Max Phase: Preclinical

Molecular Formula: C29H27F2N5O

Molecular Weight: 499.57

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C[C@@H]1CN(c2cc(=O)n(C)c3ccc(C#N)nc23)[C@@H](C)CN1C(c1ccc(F)cc1)c1ccccc1F

Standard InChI:  InChI=1S/C29H27F2N5O/c1-18-17-36(29(20-8-10-21(30)11-9-20)23-6-4-5-7-24(23)31)19(2)16-35(18)26-14-27(37)34(3)25-13-12-22(15-32)33-28(25)26/h4-14,18-19,29H,16-17H2,1-3H3/t18-,19+,29?/m0/s1

Standard InChI Key:  QBLJMEHOKNLCLR-VQSPDULUSA-N

Associated Targets(Human)

Diacylglycerol kinase alpha 73 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Diacylglycerol kinase zeta 13 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Diacylglycerol kinase alpha/zeta 14 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 499.57Molecular Weight (Monoisotopic): 499.2184AlogP: 4.77#Rotatable Bonds: 4
Polar Surface Area: 65.16Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.70CX LogP: 4.77CX LogD: 4.69
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.40Np Likeness Score: -1.00

References

1. Abdel-Magid AF..  (2020)  Cancer Immunotherapy through the Inhibition of Diacylglycerol Kinases Alpha and Zeta.,  11  (6): [PMID:32550982] [10.1021/acsmedchemlett.0c00118]

Source